These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9832985)
41. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Gibbs RB Horm Behav; 1999 Dec; 36(3):222-33. PubMed ID: 10603286 [TBL] [Abstract][Full Text] [Related]
42. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E Pol J Pharmacol; 2002; 54(6):615-23. PubMed ID: 12866716 [TBL] [Abstract][Full Text] [Related]
43. Effects of metrifonate on escape and avoidance learning in young and aged rats. van Der Staay FJ; Hinz VC; Schmidt BH Behav Pharmacol; 1996 Jan; 7(1):56-64. PubMed ID: 11224394 [TBL] [Abstract][Full Text] [Related]
44. Performance- and task-dependent effects of the dopamine D1/D5 receptor agonist SKF 38393 on learning and memory in the rat. Amico F; Spowart-Manning L; Anwyl R; Rowan MJ Eur J Pharmacol; 2007 Dec; 577(1-3):71-7. PubMed ID: 17900561 [TBL] [Abstract][Full Text] [Related]
45. Sedative and cardiopulmonary effects of medetomidine hydrochloride and xylazine hydrochloride and their reversal with atipamezole hydrochloride in calves. Rioja E; Kerr CL; Enouri SS; McDonell WN Am J Vet Res; 2008 Mar; 69(3):319-29. PubMed ID: 18312129 [TBL] [Abstract][Full Text] [Related]
46. Benzodiazepine receptor stimulation blocks scopolamine-induced learning impairments in a water maze task. Smythe JW; Murphy D; Costall B Brain Res Bull; 1996; 41(5):299-304. PubMed ID: 8924041 [TBL] [Abstract][Full Text] [Related]
47. Atipamezole, an alpha 2 antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects. Riekkinen P; Sirviö J; Riekkinen M; Lammintausta R; Riekkinen P Pharmacol Biochem Behav; 1992 Mar; 41(3):611-4. PubMed ID: 1350102 [TBL] [Abstract][Full Text] [Related]
48. Overexpression of alpha2C-adrenoceptors impairs water maze navigation. Björklund M; Sirviö J; Riekkinen M; Sallinen J; Scheinin M; Riekkinen P Neuroscience; 2000; 95(2):481-7. PubMed ID: 10658628 [TBL] [Abstract][Full Text] [Related]
49. Effects of atipamezole, a novel alpha 2-adrenoceptor antagonist, in open-field, plus-maze, two compartment exploratory, and forced swimming tests in the rat. Kauppila T; Tanila H; Carlson S; Taira T Eur J Pharmacol; 1991 Nov; 205(2):177-82. PubMed ID: 1687467 [TBL] [Abstract][Full Text] [Related]
50. Dose- and parameter-dependent effects of atipamezole, an alpha 2-antagonist, on the performance of rats in a five-choice serial reaction time task. Sirviö J; Jäkälä P; Mazurkiewicz M; Haapalinna A; Riekkinen P; Riekkinen PJ Pharmacol Biochem Behav; 1993 May; 45(1):123-9. PubMed ID: 8100071 [TBL] [Abstract][Full Text] [Related]
51. The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. Haapalinna A; Sirviö J; MacDonald E; Virtanen R; Heinonen E Eur J Pharmacol; 2000 Jan; 387(2):141-50. PubMed ID: 10650154 [TBL] [Abstract][Full Text] [Related]
52. Effects of (R)-alpha-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze. Smith CP; Hunter AJ; Bennett GW Psychopharmacology (Berl); 1994 May; 114(4):651-6. PubMed ID: 7855228 [TBL] [Abstract][Full Text] [Related]
53. Modulation of EEG rhythmicity and spike activity in the rat hippocampus by systemically administered tetrahydroaminoacridine, scopolamine and atipamezole. Valjakka A; Lukkarinen K; Koivisto E; Riekkinen P; Miettinen R; Airaksinen MM; Lammintausta R; Riekkinen P Brain Res Bull; 1991 May; 26(5):739-45. PubMed ID: 1682015 [TBL] [Abstract][Full Text] [Related]
54. Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. Pederson ES; Harding JW; Wright JW Regul Pept; 1998 Jun; 74(2-3):97-103. PubMed ID: 9712169 [TBL] [Abstract][Full Text] [Related]
55. Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole. Haapalinna A; Sirviö J; Lammintausta R Eur J Pharmacol; 1998 Apr; 347(1):29-40. PubMed ID: 9650845 [TBL] [Abstract][Full Text] [Related]
56. Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Jolkkonen J; Puurunen K; Rantakömi S; Härkönen A; Haapalinna A; Sivenius J Eur J Pharmacol; 2000 Jul; 400(2-3):211-9. PubMed ID: 10988336 [TBL] [Abstract][Full Text] [Related]
57. Forelimb use after focal cerebral ischemia in rats treated with an alpha 2-adrenoceptor antagonist. Karhunen H; Virtanen T; Schallert T; Sivenius J; Jolkkonen J Pharmacol Biochem Behav; 2003 Feb; 74(3):663-9. PubMed ID: 12543233 [TBL] [Abstract][Full Text] [Related]
58. Differences in the acquisition process and the effect of scopolamine on radial maze performance in three strains of rats. Higashida A; Ogawa N Pharmacol Biochem Behav; 1987 Jul; 27(3):483-9. PubMed ID: 3659071 [TBL] [Abstract][Full Text] [Related]
59. Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns. Björklund M; Sirviö J; Sallinen J; Scheinin M; Kobilka BK; Riekkinen P Neuroscience; 1999; 88(4):1187-98. PubMed ID: 10336129 [TBL] [Abstract][Full Text] [Related]
60. Lack of relationship between thalamic oscillations and attention in rats: differential modulation by an alpha-2 antagonist. Puumala T; Björklund M; Ruotsalainen S; Riekkinen M; Jäkälä P; Haapalinna A; Björk E; Riekkinen P; Sirviö J Brain Res Bull; 1997; 43(2):163-71. PubMed ID: 9222529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]